Risk factors for Visceral Leishmaniasis relapse in Immunocompetent patients following treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India

Source: PLOS Medicine

Comments are closed.



Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons